Researchers examined the generational differences across the population of the UK in risk perceptions, emotions, and beliefs about climate change and climate engagement.
LY-4170156 by Eli Lilly and Co for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes